CIK 0001653087 · Accelerated filer<br>Smaller reporting company
Alector, Inc.
Sign in to watch- Ticker
- ALEC
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 822933343
- Phone
- 415-231-5660
- Business address
- 131 OYSTER POINT BLVD., SUITE 600, SOUTH SAN FRANCISCO, CA, 94080
- Former names
- Alector LLC
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 4 Open-market sale Chief Executive Officer sold 5,647 shares at $5.19 ($29,333)
- 4 Open-market sale President and Head of R&D sold 6,214 shares at $5.19 ($32,277)
- 4 Open-market sale Chief Medical Officer sold 2,771 shares at $5.19 ($14,393)
- 4 Open-market sale Chief Financial Officer sold 1,114 shares at $5.19 ($5,786)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 4 Other disposition Director disposed of 598,533 shares (other)
- 4 Other disposition 10% owner disposed of 598,533 shares (other)
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 8-K Event Bylaws or fiscal year change · Shareholder vote results
- 4 Grant or award Director acquired 26,250 shares (grant or award)
- 4 Grant or award Director acquired 26,250 shares (grant or award)
- 4 Grant or award Director acquired 26,250 shares (grant or award)
- 4 Grant or award Director acquired 26,250 shares (grant or award)
- 4 Grant or award Director acquired 26,250 shares (grant or award)
Page 14 of 32 · 631 filings